SNSGF yields 2000000.00% · JNJ yields 2.13%● Live data
📍 SNSGF pulled ahead of the other in Year 1
Combined, SNSGF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SNSGF + JNJ for your $10,000?
Sense Technologies, Inc. develops and markets automotive safety devices that enhance driver awareness of people or obstacles located in vehicle blind spots in the United States. It offers Guardian Alert Doppler awareness system, which warns vehicle drivers of the presence of people or obstacles in blind spots that exist behind their vehicles when backing up. The company markets its Guardian Alert product primarily to automobile and truck dealers, fleet operators, and other after-market automotive industry participants. It also offers ScopeOut, a system of specially designed mirrors that are placed at specific points on automobiles, trucks, sport utility vehicles, or commercial vehicles to provide drivers a complete view behind the vehicle. The company markets its ScopeOut product to department stores and other retailers as an after-market automotive safety product, as well as sells online at sensetech.com. The company was formerly known as Graham Gold Mining Corporation and changed its name to Sense Technologies, Inc. in October 1997. Sense Technologies, Inc. was founded in 1988 and is based in Grand Island, Nebraska.
Full SNSGF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.